Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account
Next week on the stock market

23 August 2019

No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.

The summer silly season never really got started this year, with M&A announcements and profit warnings salted throughout August to supplement the thinner reporting schedule. The week ahead of the bank holiday has plenty in the diary to keep investors interested, and given recent trends we wouldn’t be surprised to see an unscheduled announcement or two as well.

Among the companies we’ll be covering:

  • A growing order book remains our main metric of success for Petrofac, recent trends have been weak so we’ll be looking closely at the outlook statement
  • Travel remains WH Smith’s focus over the summer season
  • Growth in private sector clients and margin improvements are the order of the day at EMIS

FTSE 350 and selected other stocks reporting next week:

No FTSE 350 reporters.
Bunzl Half year results
Polymetal Half year results
Diploma Q3 trading statement
James Fisher and Sons Half year results
Petrofac* Half year results
WH Smith Pre-close trading statement
Amigo Half year results
Hunting Half year results
Hays Full year results
BBGI SICAV SA Half year results
Grafton Group Half year results
EMIS* Half year results

*Companies on which we will be writing research.


We’ve had a half year trading statement from Petrofac, but we’re hoping half year results can fill in some of the blanks.

Firstly, we’d like to know if there’s any more information on the outlook for Petrofac’s order book. That follows concerns reputational damage from the Serious Fraud Office (SFO) investigation, is limiting new contract wins. Petrofac finished the half with an order book worth $8.9bn, compared to $9.6bn at the end of 2018.

Otherwise the main focus will be the group’s efforts to reduce costs and protect margins. As the order book shrinks, revenues will eventually follow suit, and that means Petrofac needs to slim-down its cost bases if it’s to protect margins. So far we’ve seen some significant headcount reductions, and that’s a trend we would expect to continue.

Find out more about Petrofac

Sign up for updates on Petrofac

WH Smith

Shoppers might think of WH Smith as a high street stalwart, but it’s the strong travel business that holds the attraction for investors.

As we edge towards the anniversary of Smith’s £155m acquisition of US airport retailer, InMotion, investors should focus on the international airport business in particular. It’s a key segment within the group’s lucrative and growing travel retail business that most Brits are more familiar with from train stations. Of the 867 travel outlets, 286 are international, and mostly in airports. This trading statement should show if the division is still moving in the right direction.

Tough trading conditions mean we think it’s likely sales are still in decline in the high street business – total revenue and repeat sales performance dipped 1% and 2% respectively at the half year. Moderating the impact of falling high street sales on profits has been one of the group’s key achievements in recent years, unfortunately that means store closures are likely to have continued.

Find out more about WH Smith


Following the disposal of the non-core Specialist and Care business, EMIS is a streamlined and cash richer business.

Shedding excess weight in the form of disposals is only one part of CEO Andy Thorburn’s plan though. EMIS remains highly dependent on the NHS as a customer, and while it’s good to have such a giant punter on the books – it does leave EMIS vulnerable to ups and downs of government spending. Investors will therefore want to know how progress is going in the private sector. The goal here is for private care to make up half of revenues in the future.

Trading at the half year point is in line with Board expectations, and revenue is expected to increase ahead of last year’s 7% growth. Beyond the top line though, EMIS traditionally has excellent cash conversion – and net cash improved last year, despite extra investment. We suspect this is a pattern we could see again.

Find out more about Emis

Sign up for updates on Emis

Unless otherwise stated estimates are a consensus of analyst forecasts provided by Thomson Reuters. These estimates are not a reliable indicator of future performance. Past performance is not a guide to the future. Investments rise and fall in value so investors could make a loss.

This article is not advice or a recommendation to buy, sell or hold any investment. No view is given on the present or future value or price of any investment, and investors should form their own view on any proposed investment. This article has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is considered a marketing communication. Non-independent research is not subject to FCA rules prohibiting dealing ahead of research, however HL has put controls in place (including dealing restrictions, physical and information barriers) to manage potential conflicts of interest presented by such dealing. Please see our full non-independent research disclosure for more information.

Share via email Share on Facebook Share on Twitter Share on Linkedin
Investment notes
No news or research item is a personal recommendation to deal. All investments can fall as well as rise in value so you could get back less than you invest.
Share via email Share on Facebook Share on Twitter Share on Linkedin